ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980

DCPC Bard Approves Concepts For New Grant Programs

November 13, 1992

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005

CPSC Relies On NCI Findings For New Policy

July 21, 1978